Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 11Squamous Cell Carcinoma of Head and Neck 8Oropharyngeal Neoplasms 7Cholangiocarcinoma 7Pancreatic Neoplasms 6Lung Neoplasms 6Urinary Bladder Neoplasms 5Ovarian Neoplasms 4Mouth Neoplasms 4Laryngeal Neoplasms 4Gallbladder Neoplasms 4Carcinoma 4Sarcoma 3Hypopharyngeal Neoplasms 3Fallopian Tube Neoplasms 3Urethral Neoplasms 2Stomach Neoplasms 2Peritoneal Neoplasms 2Paranasal Sinus Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Mesothelioma, Malignant 2Klatskin Tumor 2Colorectal Neoplasms 2Vulvar Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ureteral Neoplasms 1Testicular Neoplasms 1Stomatitis 1

Interventions

Radiotherapy 1Radiation 1Platinum 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT04580771 2026-04-15

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
22 enrolled
Gynecologic

Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified

Data powered by HemOnc (CC BY 4.0) Colophon âš¡